Eton Pharmaceuticals Announces Submission of Prior Approval Supplement to Expand Indication of KHINDIVI® (hydrocortisone) Oral Solution

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. XENE
2. SPY
3. HUBS
4. NUE
5. ONON
6. AAPL
7. TRMD
8. AZN
9. NVDA
10. USO

Go back to Eton Pharmaceuticals Announces Submission of Prior Approval Supplement to Expand Indication of KHINDIVI® (hydrocortisone) Oral Solution
(NASDAQ: ETON) Delayed: 56.62 -0.45 (0.79%)
Previous Close $57.07    52 Week High $ 
Open $56.97    52 Week Low $ 
Day High $57.50    P/E N/A 
Day Low $56.15    EPS $ 
Volume 94,415